Trial Profile
An open label study to investigate the pharmacokinetics of faldaprevir co-administered with itraconazole in healthy subjects
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jan 2022
Price :
$35
*
At a glance
- Drugs Faldaprevir (Primary) ; Itraconazole
- Indications Hepatitis C
- Focus Pharmacokinetics
- 12 Dec 2015 New trial record